enterozyn kids

What is Enterozyn and what does it consist of ?

Enterozyn kids is a combination that aims to relieve the causes (viruses and bacteria) and symptoms (diarrhea, vomiting, etc.) of acute pediatric gastroenteritis.

  1. A) It consists of the “friendly bacterium” bifidobacterium B94,aimed at the immediate cessation of diarrhea. Instantly kills viruses and germs, stimulates the local immune system (T lymphocytes, Interferon, bacteriocin production)
  1. B) The prebiotic inulin that feeds the bifidobacterium B94, but also all the good bacteria of the intestinal flora, contributing to the rapid eradication of the pathogen.

Inulin is not broken down in the stomach and small intestine, but is transported unchanged in the large intestine (where there is a problem). For this reason, it helps the other 2 active ingredients of Enterozyn kids to reach the large intestine intact, in huge quantities and in fact on an empty stomach.

  1. C) Biotin (B7) which regenerates the intestinal epithelial cells, which have been damaged due to infection, creating a new, clean, inflammation-free epithelium and maintaining it for a long time.

The Enterozyn kids combination also transports all the killed bacteria, viruses, damaged cells, toxins outside the intestine, quickly restoring its normal function.

Finally, by stopping the uncontrolled production of serotonin, nausea and vomiting immediately stop

What do we achieve with Enterozyn?

All our studies show:

  1. long-term detection in the stool (up to 38 days after the end of treatment), and therefore its large colonization in the small intestine.
  2. rapid escape of symptoms (diarrhea, vomiting, nausea)
  3. Immediate relief of the patient
  4. Protection against infection, because it competes equally with viruses and bacteria and stops inflammation and regenerates the intestinal epithelium.

It is a combination designed exactly for the causes and symptoms of acute pediatric gastroenteritis.

Dosage

Amazing and soft strawberry flavor.

1 sachet daily 30 ‘before meals.

Dissolve the contents of the sachet in a little water.

Bibliography and comments

1. Su et al. 2007. Prebiotics enhance survival and prolong the retention period of specific probiotic inocula in an in vivo murine model. J Appl Microbiol. 2007 Dec;103(6):2392-400.
2. Islek et al. 2014. The role of Bifidobacterium lactis B94 plus inulin in the treatment of acute infectious diarrhea in children. Turk J Gastroenterol. 2014 Dec;25(6):628-33. doi:
10.5152/tjg.2014.14022.
3. Erdogan et al. 2012. The Comparition of the Efficacy of Two Different Probiotics in Rotavirus Gastroenteritis in Children. Journal of Tropical Medicine. Volume 2012, Article ID 787240, 5
page
4. ESPGHAN-European Society for Pediatric Gastroenterology, Hepatology, and Nutrition 2014. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European
Society for Pediatric Infectious Diseases Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe: Update 2014. JPGN 59 (1), 132-152.
5. Szajewska et al. 2014. Use of probiotics for management of acute gastroenteritis: A position paper by the ESPGHAN working group for probiotics and prebiotics. JPGN 58 (4), 531-539.
6. Lynen Jansen et al. 2014. Development of Gastrointestinal Infectious Diseases between 2000 and 2012. Z Gastroenterol 2014; 52(6): 549-557.
7. Liu et al. 2016. Global, regional, and national causes of under-5 mortality in 2000-2015: an updated systematic analysis with implications for the sustainable development goals.
The Lancet 388, 17/24/31, 3027-35.
8. Wilking et al. 2013. Acute gastrointestinal illness in adults in Germany: a population-based telephone survey. Epidemiol Infect 141, 2365-2375.
9. Guarino et al. 2014. European Society for Pediatric gastroenetrology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases Evidence_Based Guidlines for the
Management of Acute Gastroenteritis in Children in Europe: Update 2014. JPGN 59 (1), 132-152.
10. RKI-Robert Koch Institut 2012. Epidemiologisches Bulletin 44/2012, 441-452.
11. Elliott 2007. Acute gastroenteritis in children. BMJ (6), 334(7583): 35–40.
12. Burkhart 1999. Management of Acute Gastroenteritis in Children. American Family Physician 60(9), 2555-2563. A.
13. Zhang et al. 2008 Investigation of the Immunomodulatory Effects of Lactobacillus casei and Bifidobacterium lactis on Helicobacter pylori Infection. Helicobacter 183-90.
14. Franceschi et al. 2010. Probiotics and Hy pylori infections. In: Bioactive foods in promoting health: Probiotics and prebiotics. Elsevier. 259-65.
15. Lorrot et al. 2007. How do the rotavirus NSP4 and bacterial enterotoxins lead differently to diarrhea? Virology Journal 2007, 4:31.
16. Field 2003. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest, 111(7): 931-943.
17. Sharinginhealth.ca. Vibrio cholerae. http://www.sharinginhealth.ca/pathogens/bacteria/vibrio_cholerae.html
18. Galán et al. 2016. In vitro antivirla activity of Lactobacillus casei and Bifidobacterium adolescentis against rotavirus infection monitored by NSP4 protein production. Applied
Microbiology 120: 1041-1051.
19. Zabihollahi et al. 2012. Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo. Journal of Pharmaceutical Sciences 20: 53.
20. Cohen 1991. Etiology and mechanisms of acute infectious diarrhea in infants in the United States. Ournal of Peadiatrics 118(4/2): S34-S39

Skip to content